Monte Rosa Therapeutics, Inc
This role involves defining and building an agentic AI strategy to create production systems for scientists across discovery, clinical development, and commercialization. The position requires hands-on technical leadership to redesign scientific workflows around AI agents and develop the necessary data and knowledge layers. It focuses on deploying secure, auditable agentic systems with rigorous evaluation frameworks and driving adoption through partnerships and training. The role also involves mentoring the AI team and tracking advancements in foundation models to turn them into practical internal capabilities.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc didn’t post a salary, so this is our estimate from similar listings.
17% above the average for this role